Cathay Biotech Stock Forecast - 8 Period Moving Average

688065 Stock   42.84  0.22  0.51%   
The 8 Period Moving Average forecasted value of Cathay Biotech on the next trading day is expected to be 43.93 with a mean absolute deviation of 2.51 and the sum of the absolute errors of 135.66. Cathay Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cathay Biotech stock prices and determine the direction of Cathay Biotech's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cathay Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Cathay Biotech's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 6 B, whereas Total Assets are forecasted to decline to about 15.6 B.
An 8-period moving average forecast model for Cathay Biotech is based on an artificially constructed time series of Cathay Biotech daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Cathay Biotech 8 Period Moving Average Price Forecast For the 20th of December

Given 90 days horizon, the 8 Period Moving Average forecasted value of Cathay Biotech on the next trading day is expected to be 43.93 with a mean absolute deviation of 2.51, mean absolute percentage error of 16.95, and the sum of the absolute errors of 135.66.
Please note that although there have been many attempts to predict Cathay Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cathay Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Cathay Biotech Stock Forecast Pattern

Backtest Cathay BiotechCathay Biotech Price PredictionBuy or Sell Advice 

Cathay Biotech Forecasted Value

In the context of forecasting Cathay Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cathay Biotech's downside and upside margins for the forecasting period are 39.72 and 48.14, respectively. We have considered Cathay Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
42.84
43.93
Expected Value
48.14
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Cathay Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Cathay Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria108.0757
BiasArithmetic mean of the errors -0.5732
MADMean absolute deviation2.5123
MAPEMean absolute percentage error0.0521
SAESum of the absolute errors135.6637
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Cathay Biotech 8-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Cathay Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cathay Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
38.5042.6946.88
Details
Intrinsic
Valuation
LowRealHigh
32.1636.3547.12
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.180.180.18
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cathay Biotech. Your research has to be compared to or analyzed against Cathay Biotech's peers to derive any actionable benefits. When done correctly, Cathay Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cathay Biotech.

Other Forecasting Options for Cathay Biotech

For every potential investor in Cathay, whether a beginner or expert, Cathay Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cathay Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cathay. Basic forecasting techniques help filter out the noise by identifying Cathay Biotech's price trends.

Cathay Biotech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cathay Biotech stock to make a market-neutral strategy. Peer analysis of Cathay Biotech could also be used in its relative valuation, which is a method of valuing Cathay Biotech by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cathay Biotech Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cathay Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cathay Biotech's current price.

Cathay Biotech Market Strength Events

Market strength indicators help investors to evaluate how Cathay Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cathay Biotech shares will generate the highest return on investment. By undertsting and applying Cathay Biotech stock market strength indicators, traders can identify Cathay Biotech entry and exit signals to maximize returns.

Cathay Biotech Risk Indicators

The analysis of Cathay Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cathay Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cathay stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.